KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Verisign (VRSN) Research & Development (2016 - 2026)

Verisign has reported Research & Development over the past 18 years, most recently at $27.5 million for Q1 2026.

  • Quarterly Research & Development rose 5.77% to $27.5 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $105.1 million through Mar 2026, up 7.35% year-over-year, with the annual reading at $103.6 million for FY2025, 7.14% up from the prior year.
  • Research & Development was $27.5 million for Q1 2026 at Verisign, up from $26.5 million in the prior quarter.
  • Over five years, Research & Development peaked at $27.5 million in Q1 2026 and troughed at $20.3 million in Q2 2022.
  • The 5-year median for Research & Development is $23.8 million (2024), against an average of $23.8 million.
  • Biggest five-year swings in Research & Development: rose 12.81% in 2022 and later increased 2.48% in 2024.
  • Tracing VRSN's Research & Development over 5 years: stood at $21.5 million in 2022, then rose by 6.51% to $22.9 million in 2023, then increased by 8.73% to $24.9 million in 2024, then grew by 6.43% to $26.5 million in 2025, then rose by 3.77% to $27.5 million in 2026.
  • According to Business Quant data, Research & Development over the past three periods came in at $27.5 million, $26.5 million, and $25.4 million for Q1 2026, Q4 2025, and Q3 2025 respectively.